Low Expression of PINK1 and PARK2 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2023 Oct 14

PMID 37833780

Authors

Xiangyun Lu

Yongkun Yao

Yandi Ma

Xudong Zhang

Hao Peng

Yuhui Pei

Yulin Lu

Lianghai Wang

Affiliations

Soon will be listed here.

Abstract

Background: The Parkinson's disease (PD) gene family expression is strongly linked to tumor development and progression; PINK1 and PARK2 are essential members of the PD gene family. However, the relationship between PINK1 and PARK2 and esophageal squamous cell carcinoma (ESCC) remains unknown. This research aims to clarify the prognostic value of PINK1 and PARK2 in ESCC.

Methods: PINK1 and PARK2 protein levels in 232 ESCC specimens, and 125 matched adjacent normal tissues were detected by immunohistochemistry. The relationship between PINK1 and PARK2 protein expression and clinicopathological features were analyzed. Kaplan-Meier survival analysis was performed to estimate the prognostic value of the PINK1 and PARK2 proteins in patients. Cox univariate and multivariate analyses were used to assess the risk factors affecting the OS for patients with ESCC.

Results: PINK1 and PARK2 had low expression in ESCC. Patients with low PINK1 had worse differentiation and advanced T and TNM stages. Lower PARK2 expression was linked to lymph node metastases and an advanced TNM stage. Furthermore, reduced PINK1 and PARK2 levels were associated with a poor prognosis for ESCC. Cox univariate and multivariate analyses revealed that PINK1, PARK2, and tumor size were closely associated with the prognosis of patients with ESCC, and PARK2 was an independent risk factor for patients with ESCC. Finally, the PINK1 and PARK2 proteins were closely related and shared the same signal pathway.

Conclusions: PINK1 and PARK2 could work as tumor suppressors in ESCC and are likely to become new treatment targets for ESCC.

Citing Articles

A Multi-Omics Analysis of a Mitophagy-Related Signature in Pan-Cancer.

Agir N, Georgakopoulos-Soares I, Zaravinos A Int J Mol Sci. 2025; 26(2.

PMID: 39859167 PMC: 11765132. DOI: 10.3390/ijms26020448.

Mitochondrial Plasticity and Glucose Metabolic Alterations in Human Cancer under Oxidative Stress-From Viewpoints of Chronic Inflammation and Neutrophil Extracellular Traps (NETs).

Lee H, Lin C, Liu C, Chen P, Tsai C, Wei Y Int J Mol Sci. 2024; 25(17).

PMID: 39273403 PMC: 11395599. DOI: 10.3390/ijms25179458.

References

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Arnold M, Soerjomataram I, Ferlay J, Forman D . Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014; 64(3):381-7. DOI: 10.1136/gutjnl-2014-308124. View

Zhao Y, Zhao W, Li J, Lin S, Li L, Ren Z . Effect of dietary consumption on the survival of esophageal squamous cell carcinoma: a prospective cohort study. Eur J Clin Nutr. 2022; 77(1):55-64. DOI: 10.1038/s41430-022-01194-3. View

Chen Y, Ye J, Zhu Z, Zhao W, Zhou J, Wu C . Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. J Clin Oncol. 2019; 37(20):1695-1703. PMC: 6638596. DOI: 10.1200/JCO.18.02122. View

Wu C, Wang Z, Song X, Feng X, Abnet C, He J . Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet. 2014; 46(9):1001-1006. PMC: 4212832. DOI: 10.1038/ng.3064. View

Lesseur C, Ferreiro-Iglesias A, McKay J, Bosse Y, Johansson M, Gaborieau V . Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 2021; 17(3):e1009254. PMC: 7968735. DOI: 10.1371/journal.pgen.1009254. View

Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M . Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun. 2017; 8:15290. PMC: 5477513. DOI: 10.1038/ncomms15290. View

Lin Y, Chen Q, Liu Q, Zhou D, Lu X, Deng X . High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer. Cancer Med. 2018; 7(3):809-819. PMC: 5852339. DOI: 10.1002/cam4.1325. View

Panicker N, Ge P, Dawson V, Dawson T . The cell biology of Parkinson's disease. J Cell Biol. 2021; 220(4). PMC: 8103423. DOI: 10.1083/jcb.202012095. View

10.

Ejma M, Madetko N, Brzecka A, Guranski K, Alster P, Misiuk-Hojlo M . The Links between Parkinson's Disease and Cancer. Biomedicines. 2020; 8(10). PMC: 7602272. DOI: 10.3390/biomedicines8100416. View

11.

Wang M, Luan S, Fan X, Wang J, Huang J, Gao X . The emerging multifaceted role of PINK1 in cancer biology. Cancer Sci. 2022; 113(12):4037-4047. PMC: 9746061. DOI: 10.1111/cas.15568. View

12.

Kia D, Zhang D, Guelfi S, Manzoni C, Hubbard L, Reynolds R . Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets. JAMA Neurol. 2021; 78(4):464-472. PMC: 7851759. DOI: 10.1001/jamaneurol.2020.5257. View

13.

Hardy J . Genetic analysis of pathways to Parkinson disease. Neuron. 2010; 68(2):201-6. PMC: 2997424. DOI: 10.1016/j.neuron.2010.10.014. View

14.

Matsuda S, Nakanishi A, Minami A, Wada Y, Kitagishi Y . Functions and characteristics of PINK1 and Parkin in cancer. Front Biosci (Landmark Ed). 2015; 20(3):491-501. DOI: 10.2741/4321. View

15.

Li C, Pan Y, Tan Y, Wang Y, Sun X . PINK1-Dependent Mitophagy Reduced Endothelial Hyperpermeability and Cell Migration Capacity Under Simulated Microgravity. Front Cell Dev Biol. 2022; 10:896014. PMC: 9300855. DOI: 10.3389/fcell.2022.896014. View

16.

Beilina A, van der Brug M, Ahmad R, Kesavapany S, Miller D, Petsko G . Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A. 2005; 102(16):5703-8. PMC: 556294. DOI: 10.1073/pnas.0500617102. View

17.

Berthier A, Navarro S, Jimenez-Sainz J, Rogla I, Ripoll F, Cervera J . PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol. 2010; 42(1):75-87. DOI: 10.1016/j.humpath.2010.05.016. View

18.

Liu Y, Lear T, Verma M, Wang K, Otero P, McKelvey A . Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1. JCI Insight. 2020; 5(11). PMC: 7308049. DOI: 10.1172/jci.insight.131834. View

19.

Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S . Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci U S A. 2017; 114(37):E7697-E7706. PMC: 5604037. DOI: 10.1073/pnas.1710366114. View

20.

Li J, Xu X, Huang H, Li L, Chen J, Ding Y . promotes cell proliferation and affects glycolysis in breast cancer. Exp Biol Med (Maywood). 2022; 247(12):985-995. PMC: 9265526. DOI: 10.1177/15353702221082613. View